BioLab: learning, training and connecting

BioLab Lead image

BioLab at OICR manages state-of-art equipment for translational cancer research and offers free educational seminars, advanced technology workshops and hands-on instrument training sessions led by instrument application specialists.

The mission of BioLab is to provide continuous education and training for the next generation of Ontario cancer researchers using existing and advanced cancer-related technologies, applications, tools and instrumentation.

BioLab Provides

BioLab offers training and access to equipment

BioLab goes beyond basic theory and training to provide application-driven experiences. BioLab training explores the full potential of state-of-art cancer research equipment from experimental design, through correct equipment usage and even covers project-driven applications.

The training sessions offered by BioLab foster collaboration in the cancer research community and provide a place to share experiences, build new collaborations and drive cancer research forward.

Who can participate?

All educational seminars, workshops, and instrument training sessions offered are free to researchers at academic institutions and hospitals in Ontario. BioLab welcomes attendees of any level of experience and training, including clinicians, scientists, fellows, interns, students and research staff.

Upcoming BioLab workshops and seminars:

Educational Seminars are lecture-based learning platforms to provide continuous education on advanced new discoveries in biotechnology and translational cancer research.

Hands-on Biotechnology Workshops are designed to meet specific research goals related to particular laboratory techniques, workflows or procedures related to cancer research. The workshops are delivered by application specialists and designed for laboratory scientists who are looking for in-depth, hands-on protocol development.

BioLab is focusing its educational offerings on immuno-oncology across five key areas:

  • Liquid Biopsy and Biomolecule detection technologies;
  • Cell imaging and quantitative analysis;
  • Cytometry for single cell omics;
  • Visualization and quantification of cancer transcriptome;
  • Innovations in digital pathology.

MACSQuant® Tyto® Flow Cell Sorter for Multiparametric Cell Sorting Based on Microchip Technology for Sterile and Gentle Cell Isolation

cell-sortingOver the years researchers have been looking to improve results of flow cell sorting via improving cell viability and functionality while retaining a GMP environment. Miltenyi Biotec, world leader in flow cytometry, now offers an opportunity to expand cell sorting capabilities with innovative microchip-based technology of the MACSQuant®Tyto® Flow Cell Sorter. This unique feature opens up new possibilities in basic research and medical applications by offering high-speed multiparameter sorting and complete cell retrieval in fully enclosed sterile environment.

Learning objectives:

  • Traditional “jet-in-air” vs. valve-based microchip-based sorting techniques;
  • Expanded applications in flow cell sorting;
  • Case studies.

Presenter: Michela Hirnak, Application Scientist, Miltenyi Biotec Inc.
Date: April 17 from 2-3 p.m.
Where: BR 6-11/12, 6th Floor West Tower, OICR​

Register at eventbrite for ACSQuant® Tyto® Flow Cell Sorter for Multiparametric Cell Sorting Based on Microchip Technology for Sterile and Gentle Cell Isolation​


Oncomine Technology and Solutions for Utilization of Liquid Biopsy Assays in Cancer Research and Clinical Practice

Image of DNAThe seminar will cover the newest tools the Oncomine technology offers, from scalable and standardized assays for DNA isolation and sequencing to targeted liquid biopsy assays and panels to identify, track and monitor tumour progression and response to treatment. The seminar will cover the Oncomine targeted and pan-cancer assays for biomarker testing from FFPE, tumour tissue and the popular Oncomine Tumor Mutation Load (TML) assay for cancer immunotherapy.

Learning objectives:

  • Oncomine NGS Oncology Introduction;
  • Targeted and Pan-Cancer Cell-Free Assays;
  • Oncomine Tumor Mutation Load (TML) Assays.

Presenter: Karen Keith, Oncology Assay Scientist, Thermo Fisher
Date: May 9 from 2-3 p.m.
Where: BR 6-11/12, 5th Floor West Tower, OICR

Register at eventbrite​ for Oncomine Technology and Solutions for Utilization of Liquid Biopsy Assays in Cancer Research and Clinical Practice


Past sessions


  • MaxCyte Flow Electroporation Technology: Choosing the Right Cell Engineering Technology from Discovery to Manufacturing
    January 29, 2019

  • Novel Automated Platforms for CRISPR-Engineered Cell Lines and Synthetic sgRNA for Primary Cell and Screening Applications
    November 29, 2018

  • PrimeFlow RNA Assay for simultaneous detection of RNA and Protein by Flow Cytometry
    Bret Samelson, PhD, Gene Expression Application Scientist, Thermo Fisher Scientific
    November 8, 2018

  • BioPlex 200 Analyzer: How to Use of xMAP Technology to Measure Complex Immune Responses
    Claude Lachance, PhD, Application Scientist, BioRad, Inc.
    September 10, 2018

  • Global Transcriptome Profiling for Better Biomarkers
    Michael Wakem, Gene Expression Application Scientist, Thermo Fisher Scientific
    September 5, 2018

  • Basics of Confocal Laser Scanning Microscopy
    Thoma Kareco, PhD, Application Scientist, Leica
    October 4, 2018

  • Tools and Techniques for Isolation and Multi-Plex Analysis of Cancer-Derived Exosomes via Flow Cytometry
    Ryan Metzler, PhD, Miltenyi Biotec | Brendan McIntyre, PhD, Miltenyi Biotec | Chris Spring, M.Sc., St. Michael’s Hospital Research Core Facilities
    October 10, 2018

  • The Moffitt Cancer Center approach to pathology diagnostics supporting the delivery of precision oncology and immune-oncology treatments
    Dr. Anthony Magliocco, M.D., F.R.C.P.C., F.C.A.P. Medical Director, Morsani Molecular Diagnostics Laboratories, Moffitt Cancer Cente
    October 16, 2018

  • Introduction to Multiphoton Microscopy and Fluorescent Lifetime Microscopy (FLIM)
    Leanne Dale, Application Scientist, Leica
    October 16, 2018

  • Three-Dimensional Organoid Cultures as In Vitro Models for Cancer Research: Applications and Prospective
    Niki Radulovitch, PhD, Scientific Manager, Core Organoid, The Princess Margaret Living Biobank (PMLB) Facilities, Toronto,
    October 24, 2018

  • Global Transcriptome Profiling for Better Biomarkers
    Michael Wakem, Gene Expression Application Scientist, Thermo Fisher Scientific
    September 5, 2018

  • The Future of Diagnosis: Learning To Recognize Similar Images In Digital Pathology
    Dr. Hamid Tizhoosh, PhD, Professor, Faculty of Engineering, University of Waterloo, KIMIA Lab
    July 31, 2018

  • OkoLab BioStation for Live Cell Imaging by Leica SP8 Microscope
    Thomas Kareco PhD, Application Scientist, Leica
    June 25, 2018

  • Circulating Tumor DNA (ctDNA): Detection and Applications in Curable Cancers
    Dr. Scott Bratman, Princess Margaret Cancer Centre
    June 11, 2018

  • Preparation of Single Cell Suspensions from Tissues for Cell RNA Sequencing by 10XGenomics
    Dr. Brendan McIntyre, PhD, Miltenyi Biotec, Adam Jerauld, Application Scientist, 10XGenomics
    May 7, 2018

  • Multiplexing and Applications of the QuantiGene™ Plex and ViewRNA™Assay in Cancer Research and Diagnostics
    Dr. Michael Shure, Application Scientist, Thermo Fisher
    May 2, 2018

  • Droplets for Cancer Detection in Liquid Biopsy
    Dr. Claude Lachance, PhD, BioRad
    April 19, 2018

  • Advancing Oncology Research with High Content Imaging and 3D Models: Technology and Application Overview
    Dr. Stephen Straub, Application Scientist, Perkin Elmer
    April 5, 2018

  • MACS Technologies for Single Cell Omics: Methods for Sample Preparation, Cell Isolation and Single Cell Analysis for Cancer Research
    Dr. Brendan McIntyre, PhD, Miltenyi Biotec
    March 29, 2018

  • Quantitative Intracellular and Intra-Nuclear Spot Analysis Using Cytation-3 Digital Microscopy
    David Selvin, Application Scientist, BioTek Instruments, Inc.
    February 13, 2018

  • Visualize Gene Expression and Genetic Variations in Tumor Microenvironment: Applications of RNAscope and BaseScope ISH Technologies
    Dr. Emily Park, Sr. Scientific Director, ACD
    February 5, 2018

Leader

Dr. Vanya Peltekova PhD
Lead, BioLab Operations, Ontario Institute for Cancer Research
All inquiries can be addressed to Dr. Peltekova at vanya.peltekova@oicr.on.ca.


Seminars and workshops are for educational purposes only and are not an endorsement of any products or services by BioLab or by OICR.